 | • レポートコード：MRC308GR10447 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の閉塞性尿路疾患治療の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の閉塞性尿路疾患治療市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 閉塞性尿路疾患治療の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
閉塞性尿路疾患治療市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・内科的治療、外科的治療
用途別セグメント
・病院、クリニック、その他
主要な市場プレーヤー
・Boston Scientific Corporation、Olympus Corporation、Teleflex Incorporated、B. Braun Melsungen AG、Applied Medical、AngioDynamics、Merit Medical Systems、Argon Medical Devices, Inc.、optimed、Cook Medical、C. R. Bard
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、閉塞性尿路疾患治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な閉塞性尿路疾患治療メーカーの企業概要、2019年～2022年までの閉塞性尿路疾患治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な閉塞性尿路疾患治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別閉塞性尿路疾患治療の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの閉塞性尿路疾患治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での閉塞性尿路疾患治療市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および閉塞性尿路疾患治療の産業チェーンを掲載しています。
・第14、15章では、閉塞性尿路疾患治療の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 閉塞性尿路疾患治療の概要
– 種類別分析（2018年vs2022年vs2029年）：内科的治療、外科的治療
– 用途別分析（2018年vs2022年vs2029年）：病院、クリニック、その他
– 世界の閉塞性尿路疾患治療市場規模・予測
– 世界の閉塞性尿路疾患治療生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Boston Scientific Corporation、Olympus Corporation、Teleflex Incorporated、B. Braun Melsungen AG、Applied Medical、AngioDynamics、Merit Medical Systems、Argon Medical Devices, Inc.、optimed、Cook Medical、C. R. Bard
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：内科的治療、外科的治療
・用途別分析2018年-2029年：病院、クリニック、その他
・閉塞性尿路疾患治療の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・閉塞性尿路疾患治療のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・閉塞性尿路疾患治療のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・閉塞性尿路疾患治療の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・閉塞性尿路疾患治療の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Obstructive Uropathy Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Obstructive Uropathy Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Medical Treatement
1.3.3 Surgical Treatment
1.4 Market Analysis by Application
1.4.1 Overview: Global Obstructive Uropathy Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Obstructive Uropathy Treatment Market Size & Forecast
1.5.1 Global Obstructive Uropathy Treatment Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Obstructive Uropathy Treatment Sales Quantity (2018-2029)
1.5.3 Global Obstructive Uropathy Treatment Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Boston Scientific Corporation
2.1.1 Boston Scientific Corporation Details
2.1.2 Boston Scientific Corporation Major Business
2.1.3 Boston Scientific Corporation Obstructive Uropathy Treatment Product and Services
2.1.4 Boston Scientific Corporation Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boston Scientific Corporation Recent Developments/Updates
2.2 Olympus Corporation
2.2.1 Olympus Corporation Details
2.2.2 Olympus Corporation Major Business
2.2.3 Olympus Corporation Obstructive Uropathy Treatment Product and Services
2.2.4 Olympus Corporation Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Olympus Corporation Recent Developments/Updates
2.3 Teleflex Incorporated
2.3.1 Teleflex Incorporated Details
2.3.2 Teleflex Incorporated Major Business
2.3.3 Teleflex Incorporated Obstructive Uropathy Treatment Product and Services
2.3.4 Teleflex Incorporated Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teleflex Incorporated Recent Developments/Updates
2.4 B. Braun Melsungen AG
2.4.1 B. Braun Melsungen AG Details
2.4.2 B. Braun Melsungen AG Major Business
2.4.3 B. Braun Melsungen AG Obstructive Uropathy Treatment Product and Services
2.4.4 B. Braun Melsungen AG Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 B. Braun Melsungen AG Recent Developments/Updates
2.5 Applied Medical
2.5.1 Applied Medical Details
2.5.2 Applied Medical Major Business
2.5.3 Applied Medical Obstructive Uropathy Treatment Product and Services
2.5.4 Applied Medical Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Applied Medical Recent Developments/Updates
2.6 AngioDynamics
2.6.1 AngioDynamics Details
2.6.2 AngioDynamics Major Business
2.6.3 AngioDynamics Obstructive Uropathy Treatment Product and Services
2.6.4 AngioDynamics Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 AngioDynamics Recent Developments/Updates
2.7 Merit Medical Systems
2.7.1 Merit Medical Systems Details
2.7.2 Merit Medical Systems Major Business
2.7.3 Merit Medical Systems Obstructive Uropathy Treatment Product and Services
2.7.4 Merit Medical Systems Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merit Medical Systems Recent Developments/Updates
2.8 Argon Medical Devices, Inc.
2.8.1 Argon Medical Devices, Inc. Details
2.8.2 Argon Medical Devices, Inc. Major Business
2.8.3 Argon Medical Devices, Inc. Obstructive Uropathy Treatment Product and Services
2.8.4 Argon Medical Devices, Inc. Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Argon Medical Devices, Inc. Recent Developments/Updates
2.9 optimed
2.9.1 optimed Details
2.9.2 optimed Major Business
2.9.3 optimed Obstructive Uropathy Treatment Product and Services
2.9.4 optimed Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 optimed Recent Developments/Updates
2.10 Cook Medical
2.10.1 Cook Medical Details
2.10.2 Cook Medical Major Business
2.10.3 Cook Medical Obstructive Uropathy Treatment Product and Services
2.10.4 Cook Medical Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cook Medical Recent Developments/Updates
2.11 C. R. Bard
2.11.1 C. R. Bard Details
2.11.2 C. R. Bard Major Business
2.11.3 C. R. Bard Obstructive Uropathy Treatment Product and Services
2.11.4 C. R. Bard Obstructive Uropathy Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 C. R. Bard Recent Developments/Updates
3 Competitive Environment: Obstructive Uropathy Treatment by Manufacturer
3.1 Global Obstructive Uropathy Treatment Sales Quantity by Manufacturer (2018-2023)
3.2 Global Obstructive Uropathy Treatment Revenue by Manufacturer (2018-2023)
3.3 Global Obstructive Uropathy Treatment Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Obstructive Uropathy Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Obstructive Uropathy Treatment Manufacturer Market Share in 2022
3.4.2 Top 6 Obstructive Uropathy Treatment Manufacturer Market Share in 2022
3.5 Obstructive Uropathy Treatment Market: Overall Company Footprint Analysis
3.5.1 Obstructive Uropathy Treatment Market: Region Footprint
3.5.2 Obstructive Uropathy Treatment Market: Company Product Type Footprint
3.5.3 Obstructive Uropathy Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Obstructive Uropathy Treatment Market Size by Region
4.1.1 Global Obstructive Uropathy Treatment Sales Quantity by Region (2018-2029)
4.1.2 Global Obstructive Uropathy Treatment Consumption Value by Region (2018-2029)
4.1.3 Global Obstructive Uropathy Treatment Average Price by Region (2018-2029)
4.2 North America Obstructive Uropathy Treatment Consumption Value (2018-2029)
4.3 Europe Obstructive Uropathy Treatment Consumption Value (2018-2029)
4.4 Asia-Pacific Obstructive Uropathy Treatment Consumption Value (2018-2029)
4.5 South America Obstructive Uropathy Treatment Consumption Value (2018-2029)
4.6 Middle East and Africa Obstructive Uropathy Treatment Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
5.2 Global Obstructive Uropathy Treatment Consumption Value by Type (2018-2029)
5.3 Global Obstructive Uropathy Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
6.2 Global Obstructive Uropathy Treatment Consumption Value by Application (2018-2029)
6.3 Global Obstructive Uropathy Treatment Average Price by Application (2018-2029)
7 North America
7.1 North America Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
7.2 North America Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
7.3 North America Obstructive Uropathy Treatment Market Size by Country
7.3.1 North America Obstructive Uropathy Treatment Sales Quantity by Country (2018-2029)
7.3.2 North America Obstructive Uropathy Treatment Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
8.2 Europe Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
8.3 Europe Obstructive Uropathy Treatment Market Size by Country
8.3.1 Europe Obstructive Uropathy Treatment Sales Quantity by Country (2018-2029)
8.3.2 Europe Obstructive Uropathy Treatment Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Obstructive Uropathy Treatment Market Size by Region
9.3.1 Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Obstructive Uropathy Treatment Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
10.2 South America Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
10.3 South America Obstructive Uropathy Treatment Market Size by Country
10.3.1 South America Obstructive Uropathy Treatment Sales Quantity by Country (2018-2029)
10.3.2 South America Obstructive Uropathy Treatment Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Obstructive Uropathy Treatment Market Size by Country
11.3.1 Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Obstructive Uropathy Treatment Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Obstructive Uropathy Treatment Market Drivers
12.2 Obstructive Uropathy Treatment Market Restraints
12.3 Obstructive Uropathy Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Obstructive Uropathy Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Obstructive Uropathy Treatment
13.3 Obstructive Uropathy Treatment Production Process
13.4 Obstructive Uropathy Treatment Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Obstructive Uropathy Treatment Typical Distributors
14.3 Obstructive Uropathy Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Obstructive Uropathy Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Obstructive Uropathy Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table 4. Boston Scientific Corporation Major Business
Table 5. Boston Scientific Corporation Obstructive Uropathy Treatment Product and Services
Table 6. Boston Scientific Corporation Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Boston Scientific Corporation Recent Developments/Updates
Table 8. Olympus Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Olympus Corporation Major Business
Table 10. Olympus Corporation Obstructive Uropathy Treatment Product and Services
Table 11. Olympus Corporation Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Olympus Corporation Recent Developments/Updates
Table 13. Teleflex Incorporated Basic Information, Manufacturing Base and Competitors
Table 14. Teleflex Incorporated Major Business
Table 15. Teleflex Incorporated Obstructive Uropathy Treatment Product and Services
Table 16. Teleflex Incorporated Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teleflex Incorporated Recent Developments/Updates
Table 18. B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors
Table 19. B. Braun Melsungen AG Major Business
Table 20. B. Braun Melsungen AG Obstructive Uropathy Treatment Product and Services
Table 21. B. Braun Melsungen AG Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. B. Braun Melsungen AG Recent Developments/Updates
Table 23. Applied Medical Basic Information, Manufacturing Base and Competitors
Table 24. Applied Medical Major Business
Table 25. Applied Medical Obstructive Uropathy Treatment Product and Services
Table 26. Applied Medical Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Applied Medical Recent Developments/Updates
Table 28. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 29. AngioDynamics Major Business
Table 30. AngioDynamics Obstructive Uropathy Treatment Product and Services
Table 31. AngioDynamics Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. AngioDynamics Recent Developments/Updates
Table 33. Merit Medical Systems Basic Information, Manufacturing Base and Competitors
Table 34. Merit Medical Systems Major Business
Table 35. Merit Medical Systems Obstructive Uropathy Treatment Product and Services
Table 36. Merit Medical Systems Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merit Medical Systems Recent Developments/Updates
Table 38. Argon Medical Devices, Inc. Basic Information, Manufacturing Base and Competitors
Table 39. Argon Medical Devices, Inc. Major Business
Table 40. Argon Medical Devices, Inc. Obstructive Uropathy Treatment Product and Services
Table 41. Argon Medical Devices, Inc. Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Argon Medical Devices, Inc. Recent Developments/Updates
Table 43. optimed Basic Information, Manufacturing Base and Competitors
Table 44. optimed Major Business
Table 45. optimed Obstructive Uropathy Treatment Product and Services
Table 46. optimed Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. optimed Recent Developments/Updates
Table 48. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 49. Cook Medical Major Business
Table 50. Cook Medical Obstructive Uropathy Treatment Product and Services
Table 51. Cook Medical Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Cook Medical Recent Developments/Updates
Table 53. C. R. Bard Basic Information, Manufacturing Base and Competitors
Table 54. C. R. Bard Major Business
Table 55. C. R. Bard Obstructive Uropathy Treatment Product and Services
Table 56. C. R. Bard Obstructive Uropathy Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. C. R. Bard Recent Developments/Updates
Table 58. Global Obstructive Uropathy Treatment Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Obstructive Uropathy Treatment Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Obstructive Uropathy Treatment Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Obstructive Uropathy Treatment, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Obstructive Uropathy Treatment Production Site of Key Manufacturer
Table 63. Obstructive Uropathy Treatment Market: Company Product Type Footprint
Table 64. Obstructive Uropathy Treatment Market: Company Product Application Footprint
Table 65. Obstructive Uropathy Treatment New Market Entrants and Barriers to Market Entry
Table 66. Obstructive Uropathy Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Obstructive Uropathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Obstructive Uropathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Obstructive Uropathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Obstructive Uropathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Obstructive Uropathy Treatment Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Obstructive Uropathy Treatment Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Obstructive Uropathy Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Obstructive Uropathy Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Obstructive Uropathy Treatment Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Obstructive Uropathy Treatment Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Obstructive Uropathy Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Obstructive Uropathy Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Obstructive Uropathy Treatment Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Obstructive Uropathy Treatment Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Obstructive Uropathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Obstructive Uropathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Obstructive Uropathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Obstructive Uropathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Obstructive Uropathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Obstructive Uropathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Obstructive Uropathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Obstructive Uropathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Obstructive Uropathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Obstructive Uropathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Obstructive Uropathy Treatment Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Obstructive Uropathy Treatment Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Obstructive Uropathy Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Obstructive Uropathy Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Obstructive Uropathy Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Obstructive Uropathy Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Obstructive Uropathy Treatment Raw Material
Table 126. Key Manufacturers of Obstructive Uropathy Treatment Raw Materials
Table 127. Obstructive Uropathy Treatment Typical Distributors
Table 128. Obstructive Uropathy Treatment Typical Customers
List of Figures
Figure 1. Obstructive Uropathy Treatment Picture
Figure 2. Global Obstructive Uropathy Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Obstructive Uropathy Treatment Consumption Value Market Share by Type in 2022
Figure 4. Medical Treatement Examples
Figure 5. Surgical Treatment Examples
Figure 6. Global Obstructive Uropathy Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Obstructive Uropathy Treatment Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Others Examples
Figure 11. Global Obstructive Uropathy Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Obstructive Uropathy Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Obstructive Uropathy Treatment Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Obstructive Uropathy Treatment Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Obstructive Uropathy Treatment Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Obstructive Uropathy Treatment Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Obstructive Uropathy Treatment by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Obstructive Uropathy Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Obstructive Uropathy Treatment Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Obstructive Uropathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Obstructive Uropathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Obstructive Uropathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Obstructive Uropathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Obstructive Uropathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Obstructive Uropathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Obstructive Uropathy Treatment Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Obstructive Uropathy Treatment Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Obstructive Uropathy Treatment Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Obstructive Uropathy Treatment Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Obstructive Uropathy Treatment Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Obstructive Uropathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Obstructive Uropathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Obstructive Uropathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Obstructive Uropathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Obstructive Uropathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Obstructive Uropathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 53. China Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Obstructive Uropathy Treatment Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Obstructive Uropathy Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Obstructive Uropathy Treatment Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Obstructive Uropathy Treatment Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Obstructive Uropathy Treatment Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Obstructive Uropathy Treatment Market Drivers
Figure 74. Obstructive Uropathy Treatment Market Restraints
Figure 75. Obstructive Uropathy Treatment Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Obstructive Uropathy Treatment in 2022
Figure 78. Manufacturing Process Analysis of Obstructive Uropathy Treatment
Figure 79. Obstructive Uropathy Treatment Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source